![](/img/cover-not-exists.png)
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent
Jameson, M B, Thompson, P I, Baguley, B C, Evans, B D, Harvey, V J, Porter, D J, McCrystal, M R, Small, M, Bellenger, K, Gumbrell, LVolume:
88
Year:
2003
Language:
english
Pages:
7
DOI:
10.1038/sj.bjc.6600992
File:
PDF, 122 KB
english, 2003